Values are expressed as mean ± standard deviation (SD), where applicable.
Phytochemical analysis of Imperata cylindrica root extract (Tables 8 and 9) revealed alkaloids, flavonoids,
tannins, saponins, steroids, terpenoids, and glycosides, with terpenoids being the most abundant (43.3%),
followed by flavonoids (10.3%), tannins (5.7%), alkaloids (5.4%), and saponins (2.25%). These findings
corroborate previous reports of high terpenoid and phenolic content, supporting the plant’s antioxidant and
pharmacological activities Okwuego, et al (2025); Mmuo et al (2024). The pronounced terpenoid content
suggests potential for inflammation modulation and oxidative stress reduction, while flavonoids and tannins may
contribute to antimicrobial activity and hemostasis. Alkaloids and saponins further enhance antimicrobial
defense and membrane interactions. Nanoencapsulation within chitosan is expected to protect these bioactive
constituents from degradation, allow controlled release, and preserve phytochemical integrity, demonstrating the
extract’s suitability as a stable, natural product-based drug delivery system with localized therapeutic efficacy.
CONCLUSION
The study successfully developed a chitosan-based nanoencapsulated formulation of Imperata cylindrica
methanolic root extract, demonstrating structural integrity, preserved bioactive constituents, and nanoscale
particle size. FTIR, UV-Vis, and XRD analyses confirmed retention of functional groups, improved
phytochemical dispersion, and partial crystallinity of mineral phases, indicating stability and structural
robustness. The encapsulated particles maintained acceptable organoleptic properties and exhibited potential for
controlled release, enhanced tissue interaction, and therapeutic activity, including anti-inflammatory,
antimicrobial, and antioxidant effects. These findings highlight the formulation as a promising natural product-
derived nanoparticle system for topical wound-healing and hemostatic applications, with potential for further in
vitro and in vivo validation.
REFERENCE
1. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM (2004). Recent advances on chitosan-based micro- and
nanoparticles in drug delivery. J Control Release. 2004;100:5–28.
https://doi.org/10.1016/j.jconrel.2004.08.010.
2. Ahmed T, Aljaeid B (2016). Preparation, characterization, and potential application of chitosan metal
nanoparticles in pharmaceutical drug delivery. Drug Des Devel Ther. 2016;10:483–507.
https://doi.org/10.2147/DDDT.S99651.
3. Ali A, Ahmed S. A (2018) review on chitosan and its nanocomposites in drug delivery. Int J Biol
Macromol. 2018;109:273–286. https://doi.org/10.1016/j.ijbiomac.2017.12.078.
4. Alonso MJ, Sánchez A. (2003) The potential of chitosan in ocular drug delivery. J Pharm Pharmacol.
2003;55:1451–1463. https://doi.org/10.1211/0022357022476.
5. Chen J, Guo Z, Tian H, Chen X.( 2016) Production and clinical development of nanoparticles for gene
delivery. Mol Ther Methods Clin Dev. 2016;3:16023. https://doi.org/10.1038/mtm.2016.23.
6. Chen LY, Chen Z, Wang CQ, Luo YH, Duan M, Liu RH. (2015) Protective effects of different extracts
of Imperata rhizoma in rats with adriamycin nephrosis. J Chin Med Mater. 2015;38:2342–2346.
7. Cui J, Chao LL, You J, Xu XD (2012). Effects of Imperata cylindrica polysaccharides on glucose and
lipid metabolism in diabetic mice. Food Sci. 2012;33:302–305.
8. Mmuo V.E and Okwuego P.O (2024) Spectrophotometric Determination Of Proximate, Vitamin B
Complex and Elemental Contents of Pigeon Peas (Cajanus Cajan) Anachem Journal, 15(1), 85-95,
DOI:https://doi.org/10.5281/zenodo.14567423
9. Nwankwo V, Okwuego P.O, Odika M (2025) Pesticide Levels in Two Fish Species from a Selection of
the Niger River, Anambra state Nigeria. Asian Journal of Fisheries and Aquatic Research Volume 27
Issue 4 Pages 45-55